NUVAIRA Funding & Investors
Nuvaira is a privately held company headquartered in Minneapolis, MN. The company's proprietary Nuvaira Lung Denervation System addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma, in a procedure called Targeted Lung Denervation (TLD).
nuvaira.comTotal Amount Raised: $204,035,440
NUVAIRA Funding Rounds
Series Unknown
$52,875
Series Unknown
$15,124,893
Series Unknown
$3,920,000
Series F
$31,337,640
Series E
$79,000,000
Series E Investors
U.S. Venture Partners (USVP)Endeavour VisionLightstone VenturesMorgenthaler VenturesVersant VenturesAdvanced Technology VenturesSplit Rock PartnersWindham Venture PartnersRichard King Mellon FoundationQiming Venture PartnersVertex Ventures HCSeries Unknown
$4,000,011
Series D
$42,000,011
Series D Investors
Windham Venture PartnersVersant VenturesSplit Rock PartnersMorgenthaler VenturesAdvanced Technology VenturesVertex Ventures HCVertex VenturesSeries C
$10,000,000
Series C Investors
Advanced Technology VenturesMorgenthaler VenturesSplit Rock PartnersVersant VenturesSeries B
$10,600,000
Series B Investors
Advanced Technology VenturesMorgenthaler VenturesSplit Rock PartnersVersant VenturesSeries A
$5,000,000
Series A Investors
Morgenthaler VenturesSeries A
$3,000,000
Series A Investors
Split Rock PartnersVersant Ventures
Funding info provided by Diffbot.